16:02 Dec 20
Lupin Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Lupin Ltd.
84/100 High Financial Strength
Quality39/100 Mid Valuation
Valuation65/100 Technically Moderately Bullish
TechnicalSWOT
Strength
18
Weakness
2
Opportunity
1
Threat
1
98.11K
Market Cap (Cr)
37.36
PE Ratio
6.27
Price to Book Ratio
56.33
RSI
9.56 %
Net Profit Margin
Rating Based on 10 Analysts
Buy
60%
Hold
30%
Sell
10%
Buy
Analyst Price Target
The average price target is 2152.6 with a high estimate of 2750 and low estimate of 1600
Current 2150.70
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
